|4Feb 7, 4:03 PM ET

Gilmore Nanci 4

4 · SANUWAVE Health, Inc. · Filed Feb 7, 2025

Insider Transaction Report

Form 4
Period: 2025-01-31
Gilmore Nanci
Chief Commercial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2025-01-31$15.67/sh+1,571$24,6181,571 total
    Exercise: $27.70Exp: 2030-01-31Common Stock (1,571 underlying)
Footnotes (2)
  • [F1]Option shares were fully vested at the grant date.
  • [F2]These options were granted in lieu of a portion of the reporting person's 2024 annual cash bonus.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4